Clinical Trial Update: EINSTEIN Junior Phase II: Oral Rivaroxaban in Young Children With Venous Thrombosis [Phase 2]

View source ↗

Summary

Phase II trial update for oral rivaroxaban in young children with venous thromboembolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thromboembolism | Phase 2 | Status: COMPLETED | Results posted: 2018-06-13